SOFOSBUVIR/VELPATASVIR IS EFFECTIVE AND SAFE IN PATIENTS WITH CONCOMITANT PROTON PUMP INHIBITOR USE IN CLINICAL STUDIES

Esteban, RafaelAgarwal, KoshCalleja, Jose LuisDufour, Jean-FrancoisFlamm, StevenGordon, StuartStamm, LuisaNi, LiyunBrainard, DianaYip, Christina Sze ManKowdley, KrisCooper, CurtisAntonio Pineda, JuanCastells, LluisButi, MariaLens, Sabela2025-01-072025-01-072019-06-010017-5749https://hdl.handle.net/10668/27181enSOFOSBUVIR/VELPATASVIR IS EFFECTIVE AND SAFE IN PATIENTS WITH CONCOMITANT PROTON PUMP INHIBITOR USE IN CLINICAL STUDIESconference outputopen access10.1136/gutjnl-2019-IDDFabstracts.2681468-3288https://gut.bmj.com/content/gutjnl/68/Suppl_1/A137.1.full.pdf472085300265